Mandate

Vinge advises Ottobock on its acquisition of Exoneural Network AB

Vinge advises Ottobock, a portfolio company to EQT, on its acquisition of Exoneural Network AB a Swedish startup that has developed the so called Exopulse Mollii Suit.

The suit covers the entire body and uses electrostimulation to relax tense or spastic muscles which can improve the mobility for people with spastic diseases. Ottobock is an international medtech company and the acquisition is a step towards the expansion of its portfolio for promising neuro-orthotics.

Vinge’s team consisted of, among others, partner Christina Kokko, associates Stina Bengtsson, Jesper Lindvall and Annie Fällström (M&A), Sara Strandberg and Carl Östlund (Employment), Stojan Arnerstål och Sofia Bergenstråhle (IP), Mika Jordan (IT & GDPR), Christoffer Nordin (Regulatory) Fredrika Hjelmberg and Carla Zachariasson (Commercial Agreements) Tove Lövgren Frisk (Compliance) and Carl Bruneheim (Project assistant).

Related

Vinge advises Revivo Group on the acquisition of Premator

Revivo Group AB has acquired all the shares in Premator AB, the parent company of a group operating in the field of advanced surface treatment with extensive experience in shot blasting, anti-corrosion painting and related services. Operations are conducted in Sweden, Norway and Denmark.
September 03, 2026

Vinge advises the sellers of Berg Propulsion

Vinge has advised the sellers in connection with the sale of Berg Propulsion to Kongsberg Maritime.
September 03, 2026

Vinge advises the sellers on the sale of Nextory to Bonnier Books

Vinge has acted as legal adviser to the sellers in connection with Bonnier Books’ acquisition of Nextory, one of Europe’s leading streaming services for audiobooks and e-books. Bonnier Books is acquiring all shares in Nextory, and the transaction comprises Nextory’s operations in Sweden and internationally. The acquisition is a cash transaction and the parties have agreed not to disclose the purchase price. The transaction is subject to customary regulatory approvals.
September 02, 2026